News articles about Agilent Technologies (NYSE:A) have been trending somewhat positive recently, according to Accern. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Agilent Technologies earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 45.1438180687438 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the headlines that may have impacted Accern Sentiment’s rankings:
- Agilent Technologies, Inc. (A) CEO Michael R. Mcmullen Sells 16,492 Shares (americanbankingnews.com)
- Agilent Technologies (A) Up 10.6% Since Earnings Report: Can It Continue? – Nasdaq (nasdaq.com)
- Competent Cells Market – Global Industry Share, Analysis and Trends in 2017 (medgadget.com)
- Agilent Technologies, Inc. (A) CFO Didier Hirsch Sells 1,200 Shares (americanbankingnews.com)
Several equities analysts have commented on the stock. Wells Fargo & Company upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and increased their price target for the company from $42.92 to $60.73 in a research note on Wednesday, July 12th. BidaskClub upgraded shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. Deutsche Bank AG set a $68.00 price target on shares of Agilent Technologies and gave the company a “buy” rating in a research note on Wednesday, August 16th. Robert W. Baird increased their price target on shares of Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a research note on Wednesday, May 24th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and issued a $70.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 16th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $63.91.
Shares of Agilent Technologies (NYSE:A) traded up 0.43% during midday trading on Friday, hitting $65.96. The company had a trading volume of 2,295,974 shares. The stock’s 50-day moving average price is $62.40 and its 200-day moving average price is $58.01. The company has a market cap of $21.23 billion, a price-to-earnings ratio of 34.02 and a beta of 1.30. Agilent Technologies has a 12 month low of $42.92 and a 12 month high of $66.42.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 EPS. On average, equities research analysts forecast that Agilent Technologies will post $2.32 EPS for the current year.
In related news, CFO Didier Hirsch sold 1,200 shares of the company’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total transaction of $79,200.00. Following the completion of the transaction, the chief financial officer now directly owns 164,202 shares in the company, valued at approximately $10,837,332. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Michael R. Mcmullen sold 16,492 shares of the company’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $65.33, for a total value of $1,077,422.36. Following the transaction, the chief executive officer now owns 211,872 shares of the company’s stock, valued at $13,841,597.76. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 155,165 shares of company stock valued at $9,768,409.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.